Efficacy of Azole Derivatives, Clotrimazole, Itraconazole, and Voriconazole on Cystic Echinococcosis protoscolices: A Comparative Study

Document Type : Original Article

Authors

1 Leishmaniasis Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran

2 Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

3 Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

4 Basic Sciences in Infectious Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

10.30476/tips.2025.105577.1280

Abstract

Cystic echinococcosis (CE) presents significant public health challenges in various regions worldwide. The adverse effects and limited efficacy of current scolicidal agents, underscore the urgent need for novel therapeutics developments. This study aimed to evaluate the scolicidal effects of the azole compounds clotrimazole, itraconazole, and voriconazole on CE protoscolices. Protoscolices were aseptically harvested from ovine hepatic hydatid cysts. After confirming high viability (over 90%) through eosin staining, the protoscolices were subjected to graded concentrations of clotrimazole, itraconazole, and voriconazole. A 20% saline solution served as the positive control, while a DMSO solution (the drug solvent) used as the negative control. Following a three-hour exposure period, eosin staining and microscopic examination were employed to determine the proportion of viable protoscolices. Statistical analysis was conducted using SPSS software and ANOVA tests. The results showed that the percentage of dead protoscolices in the presence of clotrimazole was significantly higher compared to the negative control and both itraconazole and voriconazole, although it was significantly lower than the positive control. The highest mortality rate in the clotrimazole group was observed at 1024 µg/mL, corresponding to an 89.9±63.69% mortality rate. The data also indicated a statistically significant correlation between increasing clotrimazole concentration and its mortality rate (p=0.011). These findings suggest that clotrimazole exhibits superior scolicidal activity against CE protoscolices compared to itraconazole and voriconazole, indicating its potential as an anti-parasitic medication, suitable for alternative or adjunctive treatment of this debilitating disease.

Highlights

Ali Pouryousef (Google Scholar)

Kamyar Zomorodian (Google Scholar)

Bahador Sarkari (Google Scholar)

Keywords

References

1.    Deplazes P, Rinaldi L, Alvarez Rojas CA, Torgerson PR, Harandi MF, Romig T, et al. Global Distribution of Alveolar and Cystic Echinococcosis. Adv Parasitol. 2017;95:315-493. doi: 10.1016/bs.apar.2016.11.001. Epub 2017 Jan 20. PMID: 28131365.
2.    Kern P, Menezes da Silva A, Akhan O, Müllhaupt B, Vizcaychipi KA, Budke C, Vuitton DA. The Echinococcoses: Diagnosis, Clinical Management and Burden of Disease. Adv Parasitol. 2017;96:259-369. doi: 10.1016/bs.apar.2016.09.006. Epub 2017 Feb 8. PMID: 28212790.
3.    Safarpour AR, Omidian M, Pouryousef A, Fattahi MR, Sarkari B. Serosurvey of Cystic Echinococcosis and Related Risk Factors for Infection in Fars Province, Southern Iran: A Population-Based Study. Biomed Res Int. 2022 Sep 5;2022:3709694. doi: 10.1155/2022/3709694. PMID: 36105940; PMCID: PMC9467706.
4.    Sarkari B, Sadjjadi SM, Beheshtian MM, Aghaee M, Sedaghat F. Human cystic echinococcosis in Yasuj District in Southwest of Iran: an epidemiological study of seroprevalence and surgical cases over a ten-year period. Zoonoses Public Health. 2010 Mar;57(2):146-50. doi: 10.1111/j.1863-2378.2008.01200.x. Epub 2009 Jan 19. PMID: 19175567.
5.    Shahabi S, Sarkari B, Barazesh A. Echinococcus granulosus sensu stricto G1 is the predominant genotype in human and livestock isolates from Turkey and Iran, based on mitochondrial nad5 gene differentiation. Parasit Vectors. 2021 Jul 20;14(1):369. doi: 10.1186/s13071-021-04869-1. PMID: 34284817; PMCID: PMC8290630.
6.    Dehkordi AB, Sanei B, Yousefi M, Sharafi SM, Safarnezhad F, Jafari R, Darani HY. Albendazole and Treatment of Hydatid Cyst: Review of the Literature. Infect Disord Drug Targets. 2019;19(2):101-104. doi: 10.2174/1871526518666180629134511. PMID: 29956639.
7.    Emami L, Faghih Z, Ataollahi E, Sadeghian S, Rezaei Z, Khabnadideh S. Azole Derivatives: Recent Advances as Potent Antibacterial and Antifungal Agents. Curr Med Chem. 2023;30(2):220-249. doi: 10.2174/0929867329666220407094430. PMID: 35392780.
8.    Lv H, Li S, Zhang J, Liang W, Mu X, Jiang Y. In vitro effects of SB202190 on Echinococcus granulosus. Korean J Parasitol. 2013 Apr;51(2):255-8. doi: 10.3347/kjp.2013.51.2.255. Epub 2013 Apr 25. PMID: 23710097; PMCID: PMC3662073.
9.    Spicher M, Roethlisberger C, Lany C, Stadelmann B, Keiser J, Ortega-Mora LM, et al. In vitro and in vivo treatments of echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivatives. Antimicrob Agents Chemother. 2008 Sep;52(9):3447-50. doi: 10.1128/AAC.00553-08. Epub 2008 Jul 14. PMID: 18625777; PMCID: PMC2533465.
10.    Walker M, Rossignol JF, Torgerson P, Hemphill A. In vitro effects of nitazoxanide on Echinococcus granulosus protoscoleces and metacestodes. J Antimicrob Chemother. 2004 Sep;54(3):609-16. doi: 10.1093/jac/dkh386. Epub 2004 Jul 28. PMID: 15282238.
11.    Reuter S, Manfras B, Merkle M, Härter G, Kern P. In vitro activities of itraconazole, methiazole, and nitazoxanide versus Echinococcus multilocularis larvae. Antimicrob Agents Chemother. 2006 Sep;50(9):2966-70. doi: 10.1128/AAC.00476-06. PMID: 16940089; PMCID: PMC1563547.
12.    Liu C, Han X, Lei W, Yin JH, Wu SL, Zhang HB. The efficacy of an alternative mebendazole formulation in mice infected with Echinococcus multilocularis. Acta Trop. 2019 Aug;196:72-75. doi: 10.1016/j.actatropica.2019.05.009. Epub 2019 May 11. PMID: 31082364.
13.    Liu C, Zhang H, Yin J, Hu W. In vivo and in vitro efficacies of mebendazole, mefloquine and nitazoxanide against cyst echinococcosis. Parasitol Res. 2015 Jun;114(6):2213-22. doi: 10.1007/s00436-015-4412-4. Epub 2015 Mar 15. PMID: 25773183.
14.    Sabeeh E, Thamer NK, Alsaady HAM. Histopathological Study to Evaluate the Effect of Aqueous Extract of Portunuspelagicus and Mebendazole on Hydatid Cysts in Mice. Arch Razi Inst. 2023 Feb 28;78(1):87-94. doi: 10.22092/ARI.2022.358490.2231. PMID: 37312708; PMCID: PMC10258261.
15.    Xu S, Duan L, Zhang H, Xu B, Chen J, Hu W, et al. In vitro efficacies of solubility-improved mebendazole derivatives against Echinococcus multilocularis. Parasitology. 2019 Sep;146(10):1256-1262. doi: 10.1017/S0031182019000386. Epub 2019 May 6. PMID: 31057131.
16.    Nazligul Y, Kucukazman M, Akbulut S. Role of chemotherapeutic agents in the management of cystic echinococcosis. Int Surg. 2015 Jan;100(1):112-4. doi: 10.9738/INTSURG-D-14-00068.1. PMID: 25594649; PMCID: PMC4301274.
17.    Wen H, Vuitton L, Tuxun T, Li J, Vuitton DA, Zhang W, et al. Echinococcosis: Advances in the 21st Century. Clin Microbiol Rev. 2019 Feb 13;32(2):e00075-18. doi: 10.1128/CMR.00075-18. PMID: 30760475; PMCID: PMC6431127.
18.    Romig T, Deplazes P, Jenkins D, Giraudoux P, Massolo A, Craig PS, et al. Ecology and Life Cycle Patterns of Echinococcus Species. Adv Parasitol. 2017;95:213-314. doi: 10.1016/bs.apar.2016.11.002. Epub 2017 Jan 6. PMID: 28131364.
19.    Steiger U, Cotting J, Reichen J. Albendazole treatment of echinococcosis in humans: effects on microsomal metabolism and drug tolerance. Clin Pharmacol Ther. 1990 Mar;47(3):347-53. doi: 10.1038/clpt.1990.38. PMID: 2311336.
20.    Stettler M, Fink R, Walker M, Gottstein B, Geary TG, Rossignol JF, et al. In vitro parasiticidal effect of Nitazoxanide against Echinococcus multilocularis metacestodes. Antimicrob Agents Chemother. 2003 Feb;47(2):467-74. doi: 10.1128/AAC.47.2.467-474.2003. PMID: 12543645; PMCID: PMC151752.
21.    Wen H, Zhang HW, Muhmut M, Zou PF, New RR, Craig PS. Initial observation on albendazole in combination with cimetidine for the treatment of human cystic echinococcosis. Ann Trop Med Parasitol. 1994 Feb;88(1):49-52. doi: 10.1080/00034983.1994.11812834. PMID: 8192515.
22.    Zhang W, Ramamoorthy Y, Kilicarslan T, Nolte H, Tyndale RF, Sellers EM. Inhibition of cytochromes P450 by antifungal imidazole derivatives. Drug Metab Dispos. 2002 Mar;30(3):314-8. doi: 10.1124/dmd.30.3.314. PMID: 11854151.
23.    Crowley PD, Gallagher HC. Clotrimazole as a pharmaceutical: past, present and future. J Appl Microbiol. 2014 Sep;117(3):611-7. doi: 10.1111/jam.12554. Epub 2014 Jun 30. PMID: 24863842.
24.    Mordvinov VA, Shilov AG, Pakharukova MY. Anthelmintic activity of cytochrome P450 inhibitors miconazole and clotrimazole: in-vitro effect on the liver fluke Opisthorchis felineus. Int J Antimicrob Agents. 2017 Jul;50(1):97-100. doi: 10.1016/j.ijantimicag.2017.01.037. Epub 2017 May 17. PMID: 28527633.
25.    Pakharukova MY, Pakharukov YV, Mordvinov VA. Effects of miconazole/clotrimazole and praziquantel combinations against the liver fluke Opisthorchis felineus in vivo and in vitro. Parasitol Res. 2018 Jul;117(7):2327-2331. doi: 10.1007/s00436-018-5895-6. Epub 2018 May 2. PMID: 29721656.
Trends in Pharmaceutical Sciences
Volume 11, Issue 1
March 2025
Pages 51-58

Files

Share

How to cite

Statistics